STIM Neuronetics Dashboard

Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.

Company profile

Ticker

STIM

Exchange

NASDAQ

Website

www.neuronetics.com

CEO

Keith J. Sullivan

Incorporated

Delaware

Location

Pennsylvania

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Surgical & Medical Instruments & Apparatus

3M • Boston Scientific • Baxter International • Stryker • Becton, Dickinson And • Teleflex • Resmed • Hill-Rom • Integra Lifesciences • Nuvasive ...

Former names

NEURONETICS INC

SEC CIK

0001227636

Corporate docs

Articles of Incorporation & Bylaws

STIM stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

64 Biggest Movers From Yesterday

5 May 21

Gainers

Mid-Afternoon Market Update: Nasdaq Tumbles 300 Points; Neuronetics Shares Spike Higher

4 May 21

Toward the end of trading Tuesday, the Dow traded down 0.22% to 34,036.73 while the NASDAQ fell 2.2% to 13,589.88. The S&P also fell, dropping 1.06% to 4,148.42.

Why Cocrystal Pharma, Chemocentryx, Neuronetics And BioLineRx Are Moving Today

4 May 21

Cocrystal Pharma, Inc. (NASDAQ: COCP), ChemoCentryx, Inc. (NASDAQ: CCXI), Neuronetics, Inc.

Mid-Day Market Update: Maxar Technologies Falls After Q1 Results; BioLineRx Shares Climb

4 May 21

44 Stocks Moving In Tuesday's Mid-Day Session

4 May 21

Press releases

Pro users get this 30m faster

Neuronetics to Present at the William Blair 41st Annual Growth Stock Conference

20 May 21

MALVERN, Pa., May 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for

Betting Big On What Could Be The Next Great Biotech Boom

18 May 21

NEW YORK, May 18, 2021 /PRNewswire/ -- A $52-billion pain management market, a $14-billion antidepressant market, and a $4.5 trillion global wellness market are all coming together to make what could be a mega

Neuronetics® Celebrates 100,000 Treatment Milestone for Southern California TMS Center

17 May 21

MALVERN, Pa., May 17, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for

Neuronetics Reports First Quarter 2021 Financial and Operating Results

4 May 21

Neuronetics, Inc. to Host Earnings Call

4 May 21

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

4 May 21

21 Jun 21

31 Dec 21

Financial summary

Financial statements Chart STIM financial data

Quarter (USD)	Mar 21	Dec 20	Sep 20	Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Neuronetics earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	121.28M	121.28M	121.28M	121.28M	121.28M	121.28M
Cash burn (monthly)	(positive/no burn)	(positive/no burn)	2.3M	1.57M	3.06M	1.99M
Cash used (since last report)	n/a	n/a	6.2M	4.23M	8.23M	5.37M
Cash remaining	n/a	n/a	115.07M	117.05M	113.04M	115.91M
Runway (months of cash)	n/a	n/a	50.0	74.5	37.0	58.2

Beta Read what these cash burn values mean

Recent insider trades

STIM insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
4 Jun 21	Furlong Stephen	Common Stock	Sell	Dispose S	No	Yes	15.0026	2,473	37.1K	257,012
1 Jun 21	Conley Sheryl L	Common Stock	Sell	Dispose S	No	No	14.033	6,200	87K	39,672
28 May 21	Conley Sheryl L	Common Stock	Sell	Dispose S	No	No	13.777	6,800	93.68K	45,872
27 May 21	Bakewell John K	Common Stock	Grant	Aquire A	No	No	0	7,137	0	49,428
27 May 21	Conley Sheryl L	Common Stock	Grant	Aquire A	No	No	0	7,137	0	52,672
27 May 21	Muir Glenn P	Common Stock	Grant	Aquire A	No	No	0	7,137	0	89,373

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q1 2021

STIM institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

87.9% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	85	64	+32.8%
Opened positions	31	18	+72.2%
Closed positions	10	9	+11.1%
Increased positions	26	12	+116.7%
Reduced positions	17	21	-19.0%

13F shares	Current	Prev Q	Change
Total value	277.7M	170.62M	+62.8%
Total shares	22.65M	15.36M	+47.5%
Total puts	0	0
Total calls	52.2K	18.6K	+180.6%
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Polar Capital	1.25M	$15.46M	NEW
Archon Capital Management	1.21M	$15M	+13.9%
Kent Lake Capital	1.21M	$14.93M	-2.8%
First Light Asset Management	1.15M	$14.22M	NEW
Parian Global Management	1.13M	$13.97M	NEW
Royce & Associates	1.03M	$12.7M	+9.8%
Interwest Partners Viii	994.32K	$11.05M	0.0%
Vanguard	987.81K	$12.22M	+21.1%
Deerfield Management	919K	$11.37M	0.0%
Flynn James E	919K	$10.21M	0.0%

Largest transactions	Shares	Bought/sold	Change
IVSXF Investor AB	0	-1.79M	EXIT
Polar Capital	1.25M	+1.25M	NEW
First Light Asset Management	1.15M	+1.15M	NEW
Parian Global Management	1.13M	+1.13M	NEW
Next Century Growth Investors	792.71K	+792.71K	NEW
FMR	896.7K	+616.84K	+220.4%
Granite Point Capital Management	716.33K	-530.46K	-42.5%
Granahan Investment Management	555.06K	+519.07K	+1442.3%
WFC Wells Fargo & Co.	511.92K	+502.63K	+5407.5%
Redmile	500K	+500K	NEW

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Brainsway • Brainsway

Management Discussion

Total revenue for the three months ended March 31, 2021 was $12.3 million, an increase of 7% compared to the three months ended March 31, 2020 revenue of $11.5 million. During the quarter, total U.S. revenue increased by 6% and international revenue increased by 63% over the prior year quarter. The U.S. revenue growth was driven by an increase in U.S. treatment session revenue and the International revenue growth was driven by an increase in NeuroStar Advanced Therapy System sales.
U.S. NeuroStar Advanced Therapy System revenue for the three months ended March 31, 2021 was $1.8 million, a decrease of 32% compared to the three months ended March 31, 2020 revenue of $2.6 million. The decrease was primarily driven by a lower number of NeuroStar systems sold in the three months ended March 31, 2021, which was partially offset by an increase in the blended NeuroStar system average selling price quarter over quarter. For the three months ended March 31, 2021 and 2020, the Company sold 23 and 38 systems, respectively, during each period.
U.S. treatment session revenue for the three months ended March 31, 2021 was $9.6 million, an increase of 18% compared to the three months ended March 31, 2020 revenue of $8.2 million. The revenue growth was primarily driven by an increase in per click treatment session volume quarter over quarter.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: director, forward, grandfathered, inducement, inventory, involuntarily, Involuntary, newly, Prorated, secondary, served, strategic, tranche, trend, uncertainty

Removed: accurately, acquisition, Additionally, announced, arrangement, August, award, balanced, bank, capitalizing, case, category, circumvented, classified, closely, Cloud, Coil, collusion, Computing, conceived, conducted, construction, consumer, continued, Corporation, currency, decline, degree, deposit, depositor, DESCRIPTION, design, detail, detect, detected, detection, deteriorate, develop, discussed, disposition, downturn, effected, enhance, entitled, error, evaluate, expire, exposed, exposure, external, fairly, faulty, FDIC, federal, fewer, foreign, framework, fraud, GEOGRAPHICAL, Goodwill, hedging, high, hosting, HP, identified, impacting, implement, implementation, inadequate, indirectly, inflation, Inflationary, inherent, instituting, institution, July, license, limit, mandating, matter, media, Mine, mistake, monitoring, negatively, override, owed, people, performing, periodic, pertain, prevent, prevention, principally, prospectively, psychiatrist, radio, rapidly, reduce, reduction, release, reliability, responsible, resulting, retrospectively, RIF, Safety, school, secure, senior, simple, spending, Sponsoring, stated, statement, STIM, Subtopic, succeed, supervision, symbol, television, trading, Treadway, unanticipated, unauthorized, Unregistered, workforce, worsening

From filing 10-Q 2021 Q1